Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Jennifer L. McNeer

Concepts (165)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
2022
305
4.490
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
2019
36
1.790
Why?
Hematologic Diseases
3
2017
78
1.350
Why?
Hematopoietic Stem Cell Transplantation
4
2019
811
1.140
Why?
Immunotherapy
2
2020
571
1.120
Why?
Central Nervous System Diseases
1
2022
51
0.950
Why?
Central Nervous System Neoplasms
1
2022
81
0.880
Why?
Ploidies
1
2019
37
0.780
Why?
Child
15
2022
6710
0.710
Why?
Immunoglobulins, Intravenous
1
2017
63
0.660
Why?
Lymphoma, Non-Hodgkin
1
2018
265
0.600
Why?
Immune System Diseases
1
2015
24
0.600
Why?
Burkitt Lymphoma
1
2014
34
0.550
Why?
Adolescent
17
2021
9105
0.550
Why?
Arsenicals
2
2010
42
0.520
Why?
Oxides
2
2010
49
0.520
Why?
Kruppel-Like Transcription Factors
1
2014
114
0.510
Why?
Young Adult
16
2021
5954
0.480
Why?
Folic Acid
1
2011
45
0.460
Why?
Carnitine
2
2021
17
0.420
Why?
Asparaginase
2
2021
24
0.420
Why?
MAP Kinase Kinase Kinases
1
2010
49
0.420
Why?
Child, Preschool
8
2019
3752
0.400
Why?
Injections, Spinal
2
2022
48
0.390
Why?
Humans
31
2022
82932
0.390
Why?
Communicable Diseases
1
2010
69
0.390
Why?
C-Reactive Protein
1
2010
192
0.390
Why?
Antineoplastic Agents
5
2021
2358
0.360
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2022
2308
0.360
Why?
Infant
5
2019
3085
0.360
Why?
Neoplasms
3
2020
2669
0.350
Why?
Glucocorticoids
1
2010
358
0.340
Why?
Polymorphism, Genetic
1
2011
820
0.330
Why?
Polyethylene Glycols
2
2021
395
0.330
Why?
Remission Induction
5
2019
712
0.320
Why?
Translocation, Genetic
2
2016
263
0.270
Why?
Neoplasm Recurrence, Local
2
2021
1179
0.260
Why?
Male
18
2021
41802
0.250
Why?
Female
18
2021
44644
0.240
Why?
Prognosis
4
2020
3694
0.240
Why?
Etoposide
2
2019
198
0.230
Why?
Retrospective Studies
5
2022
7582
0.230
Why?
Cytogenetic Analysis
2
2019
73
0.220
Why?
Methotrexate
1
2022
260
0.220
Why?
Survivors
2
2020
193
0.220
Why?
Neoplasm, Residual
2
2019
132
0.210
Why?
Hematologic Neoplasms
2
2016
293
0.210
Why?
Leukemia, Myeloid, Acute
2
2019
661
0.200
Why?
Anthracyclines
1
2019
28
0.200
Why?
Infant, Newborn
3
2019
2427
0.200
Why?
Postoperative Complications
1
2010
2265
0.200
Why?
Leukemia
1
2021
296
0.190
Why?
Disease-Free Survival
2
2019
1194
0.190
Why?
Recurrence
1
2022
1193
0.190
Why?
Hyperbilirubinemia
1
2018
20
0.190
Why?
Adult
12
2021
25931
0.170
Why?
Mediastinal Neoplasms
1
2017
48
0.170
Why?
Risk Factors
3
2020
5396
0.170
Why?
Salvage Therapy
1
2018
224
0.170
Why?
Treatment Outcome
5
2018
7874
0.160
Why?
Point-of-Care Systems
1
2017
133
0.160
Why?
Hodgkin Disease
1
2017
166
0.160
Why?
Prevalence
2
2018
1259
0.160
Why?
Chronic Disease
1
2020
964
0.160
Why?
Escherichia coli Infections
1
2016
52
0.160
Why?
Bone Marrow Examination
1
2015
53
0.150
Why?
Philadelphia Chromosome
1
2015
31
0.150
Why?
Radiotherapy
1
2017
337
0.150
Why?
Bacteremia
1
2016
117
0.150
Why?
Drug Resistance, Neoplasm
1
2018
578
0.140
Why?
Survival Rate
4
2021
1918
0.140
Why?
Prednisone
2
2017
264
0.140
Why?
Guideline Adherence
1
2016
225
0.140
Why?
U937 Cells
2
2010
33
0.130
Why?
High-Throughput Nucleotide Sequencing
1
2016
407
0.130
Why?
Escherichia coli
1
2016
621
0.130
Why?
Leukemia, T-Cell
1
2012
18
0.130
Why?
Chromosome Aberrations
1
2014
397
0.120
Why?
Protein-Tyrosine Kinases
1
2014
307
0.120
Why?
Lymphoma, T-Cell
1
2012
44
0.120
Why?
Stress, Psychological
1
2016
307
0.120
Why?
Pediatrics
1
2017
344
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2018
936
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2014
384
0.120
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
31
0.120
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2012
113
0.120
Why?
Transplantation, Homologous
2
2012
1019
0.110
Why?
Dithiothreitol
1
2010
28
0.110
Why?
Quality of Life
1
2017
1357
0.100
Why?
Acetylcysteine
1
2010
76
0.100
Why?
Tretinoin
1
2010
125
0.100
Why?
Area Under Curve
1
2010
345
0.100
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2010
165
0.090
Why?
Protein Kinases
1
2010
223
0.090
Why?
Dexamethasone
1
2010
314
0.090
Why?
Enzyme Activation
1
2010
737
0.090
Why?
Autophagy
1
2010
163
0.090
Why?
Graft vs Host Disease
1
2010
336
0.090
Why?
Hematopoietic Stem Cells
1
2010
284
0.090
Why?
Drug Administration Schedule
1
2010
973
0.090
Why?
RNA, Small Interfering
1
2010
568
0.090
Why?
Transplantation Conditioning
1
2010
366
0.090
Why?
ROC Curve
1
2010
756
0.090
Why?
Proportional Hazards Models
1
2010
870
0.090
Why?
Age Factors
1
2012
1913
0.090
Why?
Reactive Oxygen Species
1
2010
459
0.080
Why?
Phosphorylation
1
2010
1155
0.080
Why?
Induction Chemotherapy
2
2021
137
0.080
Why?
Sex Factors
1
2010
1090
0.080
Why?
Predictive Value of Tests
1
2010
1753
0.070
Why?
Cell Line, Tumor
1
2010
2420
0.070
Why?
Genetic Variation
1
2010
1357
0.060
Why?
Prospective Studies
2
2021
4063
0.060
Why?
United States
3
2021
6273
0.060
Why?
Base Sequence
2
2016
2426
0.060
Why?
Amino Acid Sequence
2
2016
2172
0.060
Why?
Feasibility Studies
1
2021
751
0.050
Why?
Molecular Targeted Therapy
1
2021
273
0.050
Why?
Liver Function Tests
1
2018
99
0.050
Why?
Vincristine
1
2017
113
0.040
Why?
Vinblastine
1
2017
109
0.040
Why?
Bleomycin
1
2017
106
0.040
Why?
Survival Analysis
1
2021
1585
0.040
Why?
Chromosome Breakpoints
1
2016
15
0.040
Why?
Cyclophosphamide
1
2017
290
0.040
Why?
Dacarbazine
1
2017
112
0.040
Why?
Doxorubicin
1
2017
296
0.040
Why?
Needs Assessment
1
2017
140
0.040
Why?
Fusion Proteins, bcr-abl
1
2016
99
0.040
Why?
Longitudinal Studies
1
2020
971
0.040
Why?
Marital Status
1
2016
40
0.040
Why?
Disease Progression
1
2021
1468
0.040
Why?
Combined Modality Therapy
1
2020
1681
0.040
Why?
Educational Status
1
2016
173
0.040
Why?
Ultrasonography
1
2018
693
0.040
Why?
Sequence Analysis, RNA
1
2016
200
0.040
Why?
Interviews as Topic
1
2016
329
0.040
Why?
Cohort Studies
1
2021
2703
0.030
Why?
Oncogene Proteins, Fusion
1
2014
122
0.030
Why?
Anxiety
1
2016
256
0.030
Why?
Pilot Projects
1
2016
829
0.030
Why?
Genes, myc
1
2012
39
0.030
Why?
Chromosomes, Human, Pair 14
1
2012
53
0.030
Why?
Liver
1
2018
1240
0.030
Why?
Chromosomes, Human, Pair 8
1
2012
93
0.030
Why?
Depression
1
2016
413
0.030
Why?
Follow-Up Studies
1
2020
3876
0.030
Why?
Neoplasm Staging
1
2017
1920
0.030
Why?
Clinical Laboratory Techniques
1
2012
80
0.030
Why?
World Health Organization
1
2012
98
0.030
Why?
Immunophenotyping
1
2012
219
0.030
Why?
Incidence
1
2016
1637
0.030
Why?
Ubiquitin-Activating Enzymes
1
2010
7
0.030
Why?
Cross-Sectional Studies
1
2016
1419
0.030
Why?
Bone Marrow Cells
1
2012
256
0.030
Why?
Time Factors
1
2020
5497
0.030
Why?
Severity of Illness Index
1
2016
1777
0.030
Why?
MAP Kinase Signaling System
1
2010
194
0.020
Why?
Apoptosis Regulatory Proteins
1
2010
202
0.020
Why?
Microtubule-Associated Proteins
1
2010
190
0.020
Why?
Mice, Knockout
1
2010
1953
0.020
Why?
Membrane Proteins
1
2010
1204
0.020
Why?
Aged
1
2021
18473
0.020
Why?
Mice
1
2010
11106
0.010
Why?
Animals
1
2010
26911
0.010
Why?
McNeer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_